Upstream Bio (UPB) Current Assets: 2023-2025
Historic Current Assets for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $389.0 million.
- Upstream Bio's Current Assets rose 71.17% to $389.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $389.0 million, marking a year-over-year increase of 71.17%. This contributed to the annual value of $479.2 million for FY2024, which is 309.55% up from last year.
- Upstream Bio's Current Assets amounted to $389.0 million in Q3 2025, which was down 6.99% from $418.3 million recorded in Q2 2025.
- Upstream Bio's Current Assets' 5-year high stood at $479.2 million during Q4 2024, with a 5-year trough of $117.0 million in Q4 2023.
- In the last 3 years, Upstream Bio's Current Assets had a median value of $403.6 million in 2025 and averaged $347.4 million.
- Data for Upstream Bio's Current Assets shows a peak YoY skyrocketed of 309.55% (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows Upstream Bio's Current Assets stood at $117.0 million in 2023, then surged by 309.55% to $479.2 million in 2024, then skyrocketed by 71.17% to $389.0 million in 2025.
- Its last three reported values are $389.0 million in Q3 2025, $418.3 million for Q2 2025, and $453.8 million during Q1 2025.